<DOC>
	<DOC>NCT02353689</DOC>
	<brief_summary>This study aimed to investigate the effects of FODMAP contents in enteral nutrition (EN) formulas on major gastrointestinal intolerance symptoms and nutritional status in tube fed patients through the randomized, double blind and placebo-controlled trial.</brief_summary>
	<brief_title>The Effect of FODMAP Content in Tube Feeding Formula on Feeding Intolerance and Nutritional Status Improvement</brief_title>
	<detailed_description>A randomized, double-blind, placebo-controlled study was conducted on 100 tube-fed patients. Over a 14-day test period, the test group consumed EN formula containing low FODMAPs, while the placebo groups consumed EN formula containing moderate or high FODMAPs .</detailed_description>
	<criteria>tubefeeding patients EN prohibited renal dysfunction (i.e. serum creatinine &gt; 1.5 mg/dl or blood urea nitrogen &gt; 25 mg/ml) liver dysfunction (i.e. serum aspartate aminotransferase &gt; 40 U/L or alanine aminotransferase &gt; 40 U/L) uncontrollable diabetes mellitus pregnancy, breastfeeding etc. severe diarrhea</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>